Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-22

Clinical Trial Update: Comparison of Nebulized Budesonide and Intranasal Budesonide Spray in Children With Adenotonsillar Hypertrophy [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing nebulized budesonide with intranasal budesonide spray in children with adenotonsillar hypertrophy (snoring and mouth breathing).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (nebulized) (Budesonide)
  • budesonide intranasal spray (budesonide)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Snoring, Mouth Breathing | Phase 3 | Status: UNKNOWN